NASDAQ:RZLT

Rezolute Shares Edge Higher Ahead of Key FDA Week
····

Rezolute Shares Edge Higher Ahead of Key FDA Week

Rezolute shares rose 4 cents to $3.30 in premarket Nasdaq trading Monday, ahead of the company’s appearance at the Jefferies Global Healthcare Conference. The FDA has not approved Rezolute’s main drug, ersodetug, after its Phase 3 trial in congenital hyperinsulinism missed its primary endpoint. Rezolute reported $120.3 million in cash at March’s end, down from $167.9 million in June 2025.
June 1, 2026

Stock Market Today

  • Wise Shares Fall Amid Belgian Money Laundering Probe
    June 1, 2026, 11:29 AM EDT. Wise, the UK-based international money transfer firm valued at over £8bn, is under investigation by Belgian prosecutors over money laundering concerns. The probe centers on alleged use of Wise accounts for laundering proceeds from fraud, corruption, and drug trafficking, involving around €500m in transactions. Wise is cooperating with authorities and emphasizes ongoing efforts to prevent financial crime through customer verification and transaction monitoring. Following confirmation of the investigation, Wise shares dropped more than 10%. The company, which shifted its primary listing to the US in 2024, had its co-founder fined £350,000 earlier this year for regulatory violations. This investigation highlights regulatory scrutiny on fintechs amid rising concerns over financial crime compliance.